Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, double-blind, placebo-controlled, multiple-ascending-dose
study to assess the PK, safety, and tolerability of SYN-020 oral delayed release capsules
(SYN 020) in healthy adults. At least 1 exploratory PD endpoint will also be assessed.